Company / Book Value per Share
Denali Therapeutics Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.029
FY2025
5-year range
$3.276 / $9.409
FY2021-FY2025
Trend
-20.9%
vs FY2024
Sector context
#86 of 209
Health Care
What the data says
At $7.029, Denali Therapeutics Inc.'s book value per share ranks #86 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from -$14.655 in FY2016 to $31.127 in FY2017.
Based on SEC 10-K filings.
$7.029 in FY2025 with a 5-year CAGR of +4.3%.
Declined from $7.582 to $7.029 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -9.3%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
#86 of 209 in Health CareTop 41% of 209This company $7.029 Sector average $215.686
▼
-96.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, book value per share decreased 20.9% year-over-year.
- Ranks #86 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.029 | -20.9% |
| FY2024 | $8.886 | +17.2% |
| FY2023 | $7.582 | -19.4% |
| FY2022 | $9.409 | +187.2% |
| FY2021 | $3.276 | -42.4% |
| FY2020 | $5.685 | +15.5% |
| FY2019 | $4.921 | +557.2% |
| FY2018 | -$1.076 | -103.5% |
| FY2017 | $31.127 | +312.4% |
| FY2016 | -$14.655 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026